The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis
| العنوان: | The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis |
|---|---|
| المؤلفون: | Liuting Zeng, Hua Chen, Wensa Hao, Kailin Yang, Ganpeng Yu |
| المصدر: | Bioscience Reports |
| بيانات النشر: | Portland Press Ltd., 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Adult, Male, musculoskeletal diseases, Time Factors, Curcumin, WOMAC, Biophysics, Osteoarthritis, Cochrane Library, Placebo, Biochemistry, law.invention, Young Adult, 03 medical and health sciences, chemistry.chemical_compound, Curcuma, 0302 clinical medicine, Randomized controlled trial, law, Humans, Medicine, Adverse effect, Molecular Biology, Research Articles, Aged, Pain Measurement, Randomized Controlled Trials as Topic, 030203 arthritis & rheumatology, Traditional medicine, Plant Extracts, Curcuma longa Extract, business.industry, Cell Biology, Publication bias, Middle Aged, medicine.disease, Therapeutics & Molecular Medicine, Meta-analysis, Treatment Outcome, chemistry, Antirheumatic Agents, 030220 oncology & carcinogenesis, Dietary Supplements, Systematic review, Female, business |
| الوصف: | Objective: To assess the efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis (OA). Methods: The databases such as Pubmed and Cochrane Library were searched to collect the article about Curcuma longa extract and curcumin in the treatment of OA. Then, randomized controlled trials (RCTs) were selected and their data were extracted. Finally, the RevMan5.3 was utilized for risk of bias assessment and meta-analysis, the STATA15.0 were utilized for publication bias assessment, and GRADE tool were used for the evidence quality assessment of primary outcomes. Results: A total of 15 RCTs involving 1621 participants were included. (1) Compared with placebo, Curcuma longa extract and curcumin (C.) can decrease the visual analog scale (VAS) and The Western Ontario and McMaster Universities (WOMAC) score-pain, the WOMAC score-function and the WOMAC score-stiffness. In terms of adverse events, Curcuma longa extract and curcumin are comparable with those of placebo. (2) Compared with non-steroidal anti-inflammatory drugs (NSAIDs), Curcuma longa extract and curcumin have similar effects on joint pain, function and stiffness. The incidence of adverse events in Curcuma longa extract and curcumin was lower. (3) Compared with the NSAIDs group, C.+NSAIDs can also decrease the VAS and WOMAC score-pain, the WOMAC score-function and the WOMAC score-stiffness. In terms of adverse events, the addition of Curcuma longa extract and curcumin to NSAIDs did not increase adverse events. Conclusion: Curcuma longa extract and curcumin may be a safer and effective supplement for OA patients. It is recommended to use Curcuma longa extract and curcumin supplement for OA patients for more than 12 weeks. |
| تدمد: | 1573-4935 0144-8463 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa95669c0961f3ac1f274f7e005a2b4d https://doi.org/10.1042/bsr20210817 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....aa95669c0961f3ac1f274f7e005a2b4d |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15734935 01448463 |
|---|